Literature DB >> 9242585

Trichloroethylene-induced mouse lung tumors: studies of the mode of action and comparisons between species.

T Green1, G W Mainwaring, J R Foster.   

Abstract

CD-1 mice exposed to 450 ppm trichloroethylene, 6 hr/day, 5 days/week, for 2 weeks showed a marked vacuolation of lung Clara cells after the first exposure of each week and a marked increase in cell division after the last exposure of each week. The damage seen in mouse lung Clara cells is caused by an accumulation of chloral resulting from high rates of metabolism of trichloroethylene but poor clearance of chloral to trichloroethanol and its glucuronide. The activity and distribution of the key metabolizing enzymes in this pathway have been compared in mouse, rat, and human lung. While mouse lung microsomal fractions were able to metabolize trichloroethylene to chloral at significant rates, the rate in rat lung was 23-fold lower and a rate could not be detected in human lung microsomes at all. Immunolocalization of cytochrome P450IIE1 in lung sections revealed high concentrations in mouse lung Clara cells with lesser amounts in type II cells. Lower levels of enzyme could be detected in Clara cells of rat lung, but not at all in human lung sections. Western blots of lung tissues from the three species and of mouse lung Clara cells were entirely consistent with these observations. Consequently, it is highly unlikely that humans exposed to trichloroethylene are at risk from the lung damage/cell proliferation mechanism that is believed to lead to the development of tumors in the mouse lung.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242585     DOI: 10.1006/faat.1997.2312

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  8 in total

1.  Evaluation of maternal and embryotoxic effects following the treatment of chloral hydrate in Drosophila melanogaster.

Authors:  Arif Ayar; Deniz Altun Çolak; Handan Uysal
Journal:  Cytotechnology       Date:  2014-08-07       Impact factor: 2.058

Review 2.  Trichloroethylene: Mechanistic, epidemiologic and other supporting evidence of carcinogenic hazard.

Authors:  Ivan Rusyn; Weihsueh A Chiu; Lawrence H Lash; Hans Kromhout; Johnni Hansen; Kathryn Z Guyton
Journal:  Pharmacol Ther       Date:  2013-08-23       Impact factor: 12.310

3.  N-Acetyl-L-cysteine and aminooxyacetic acid differentially modulate trichloroethylene reproductive toxicity via metabolism in Wistar rats.

Authors:  Anthony L Su; Lawrence H Lash; Ingrid L Bergin; Faith Bjork; Rita Loch-Caruso
Journal:  Arch Toxicol       Date:  2021-02-18       Impact factor: 5.153

4.  Relationship of metabolism and cell proliferation to the mode of action of fluensulfone-induced mouse lung tumors: analysis of their human relevance using the IPCS framework.

Authors:  Christian Strupp; Deborah A Banas; Samuel M Cohen; Elliot B Gordon; Martina Jaeger; Klaus Weber
Journal:  Toxicol Sci       Date:  2012-04-05       Impact factor: 4.849

Review 5.  Pulmonary toxicity and carcinogenicity of trichloroethylene: species differences and modes of action.

Authors:  T Green
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 6.  Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate.

Authors:  R J Bull
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 7.  Metabolism of trichloroethylene.

Authors:  L H Lash; J W Fisher; J C Lipscomb; J C Parker
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 8.  Priorities for development of research methods in occupational cancer.

Authors:  Elizabeth M Ward; Paul A Schulte; Steve Bayard; Aaron Blair; Paul Brandt-Rauf; Mary Ann Butler; David Dankovic; Ann F Hubbs; Carol Jones; Myra Karstadt; Gregory L Kedderis; Ronald Melnick; Carrie A Redlich; Nathaniel Rothman; Russell E Savage; Michael Sprinker; Mark Toraason; Ainsley Weston; Andrew F Olshan; Patricia Stewart; Sheila Hoar Zahm
Journal:  Environ Health Perspect       Date:  2003-01       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.